Fosun International Ltd, 10% Owner at Amneal Pharmaceuticals, Inc. (AMRX), bought 327,000 shares at $2.91 ($952K) on 2019-08-06, disclosed to the SEC on 2019-08-08.
Open-market purchase of $952k AMRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| VRAY | BUY | 2019-12-10 | $46.0M | — | Filing → |
| AMRX | BUY | 2019-08-07 | $5.0M | — | Filing → |
| VRAY | BUY | 2018-08-31 | $50.0M | — | Filing → |